论文部分内容阅读
美《内科医学新闻》第14卷第9期(1981年)报道西德消息:美国丹佛退伍军人管理局医学中心戈尔德(Frank Gold)医生在西德召开的国际年轻人心肌梗塞学术讨论会上说,能使冠心病患者血小板减少存活时间的药物磺胺吡唑二酮(Sulfinpyrazone)对已进行搭桥手术病人的静脉移植闭塞以及冠心病的发展具有有益的作用。他说,对手术后的血管图进行了研究,确定了磺胺吡唑二酮对冠状搭桥手术病人的作用。
US Medical News 14 (9) (1981) reported West Germany: the United States Denver Veterans Administration Medical Center Dr. Gold (Frank Gold) held in West Germany International Symposium on myocardial infarction Said Sulfinpyrazone, a drug that can reduce the survival time of thrombocytopenic patients in patients with coronary heart disease, has a beneficial effect on vein graft occlusion and coronary heart disease in patients undergoing bypass surgery. He said that after the operation of the vascular map was studied to determine the effect of sulfadiazine dione on coronary bypass surgery patients.